| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Creative Peptides | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.creative-peptides.com | |||
![]() | +1 (631) 624-4882 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@creative-peptides.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Carbosynth China Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.carbosynth.cn | |||
![]() | +86 (512) 6260-5585 | |||
![]() | +86 (512) 6260-5576 | |||
![]() | sales@carbosynth.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink Standard supplier since 2016 | ||||
| BeLang Pharma Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.belangpharma.com | |||
![]() | +86 13885682355 | |||
![]() | info@belangpharma.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2019 | ||||
| chemBlink Standard supplier since 2019 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Classification | Biochemical >> Inhibitor >> Neuronal signaling >> Dopamine receptor agonist |
|---|---|
| Name | Pergolide mesylate salt |
| Synonyms | 8beta-[(Methylthio)methyl]-6-propylergoline methanesulfonate salt |
| Molecular Structure | ![]() |
| Molecular Formula | C19H26N2S.CH4O3S |
| Molecular Weight | 410.60 |
| CAS Registry Number | 66104-23-2 |
| EC Number | 636-270-7 |
| Hazard Symbols | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R28 Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Safety Statements | S28;S36/37;S45 Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transport Information | UN 1544 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Pergolide mesylate salt |